Global mRNA Vaccine Core Enzyme Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 104
Published Date: 23 Sep 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global mRNA Vaccine Core Enzyme market size was valued at USD 3965.6 million in 2022 and is forecast to a readjusted size of USD 3349.5 million by 2029 with a CAGR of -2.4% during review period.
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development.
mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs. In this report, mRNA vaccine core enzyme includes RNA Polymerase, Capping Enzyme, 2'-O-Methyltransferase, Inorganic Pyrophosphatase, Poly (A) Polymerase, RNase Inhibitor, RNA Polymerase, Restriction Enzyme, DNase I, etc.
mR
In the global market, the key players of mRNA Vaccine Core Enzyme are mainly Thermo Fisher, NEB, TriLink Bio Technologies, Merck, ect. The top three players within this industry hold about 40% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, with North America accounting for about 38% of the global market share. The product can be classified on the basis of enzyme type into capsidases, 2′O-methyltransferases, inorganic pyrophosphatases, poly(A) polymerases, ribonuclease inhibitors, RNA polymerases, restriction endonucleases, deoxyribonucleases I, and other enzymes. These products are widely used by biopharmaceutical companies, academic and research institutions.
The Global Info Research report includes an overview of the development of the mRNA Vaccine Core Enzyme industry chain, the market status of Biopharmaceutical Companies (Capping Enzyme, 2'-O-Methyltransferase), Academic and Research Institutes (Capping Enzyme, 2'-O-Methyltransferase), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Vaccine Core Enzyme.
Regionally, the report analyzes the mRNA Vaccine Core Enzyme markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Vaccine Core Enzyme market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Vaccine Core Enzyme market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Vaccine Core Enzyme industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Enzyme Type (e.g., Capping Enzyme, 2'-O-Methyltransferase).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Vaccine Core Enzyme market.
Regional Analysis: The report involves examining the mRNA Vaccine Core Enzyme market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Vaccine Core Enzyme market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Vaccine Core Enzyme:
Company Analysis: Report covers individual mRNA Vaccine Core Enzyme players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Vaccine Core Enzyme This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biopharmaceutical Companies, Academic and Research Institutes).
Technology Analysis: Report covers specific technologies relevant to mRNA Vaccine Core Enzyme. It assesses the current state, advancements, and potential future developments in mRNA Vaccine Core Enzyme areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Vaccine Core Enzyme market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Vaccine Core Enzyme market is split by Enzyme Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Enzyme Type, and by Application in terms of value.
Market segment by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Market segment by players, this report covers
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Vaccine Core Enzyme product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Vaccine Core Enzyme, with revenue, gross margin and global market share of mRNA Vaccine Core Enzyme from 2018 to 2023.
Chapter 3, the mRNA Vaccine Core Enzyme competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Enzyme Type and application, with consumption value and growth rate by Enzyme Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and mRNA Vaccine Core Enzyme market forecast, by regions, enzyme type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Vaccine Core Enzyme.
Chapter 13, to describe mRNA Vaccine Core Enzyme research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of mRNA Vaccine Core Enzyme
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Vaccine Core Enzyme by Enzyme Type
1.3.1 Overview: Global mRNA Vaccine Core Enzyme Market Size by Enzyme Type: 2018 Versus 2022 Versus 2029
1.3.2 Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type in 2022
1.3.3 Capping Enzyme
1.3.4 2'-O-Methyltransferase
1.3.5 Inorganic Pyrophosphatase
1.3.6 Poly (A) Polymerase
1.3.7 Rnase Inhibitor
1.3.8 RNA Polymerase
1.3.9 Restriction Enzyme
1.3.10 Dnase I
1.3.11 Others
1.4 Global mRNA Vaccine Core Enzyme Market by Application
1.4.1 Overview: Global mRNA Vaccine Core Enzyme Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biopharmaceutical Companies
1.4.3 Academic and Research Institutes
1.5 Global mRNA Vaccine Core Enzyme Market Size & Forecast
1.6 Global mRNA Vaccine Core Enzyme Market Size and Forecast by Region
1.6.1 Global mRNA Vaccine Core Enzyme Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global mRNA Vaccine Core Enzyme Market Size by Region, (2018-2029)
1.6.3 North America mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
1.6.4 Europe mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
1.6.6 South America mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Product and Solutions
2.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 NEB
2.2.1 NEB Details
2.2.2 NEB Major Business
2.2.3 NEB mRNA Vaccine Core Enzyme Product and Solutions
2.2.4 NEB mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 NEB Recent Developments and Future Plans
2.3 TriLink Bio Technologies
2.3.1 TriLink Bio Technologies Details
2.3.2 TriLink Bio Technologies Major Business
2.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Solutions
2.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TriLink Bio Technologies Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck mRNA Vaccine Core Enzyme Product and Solutions
2.4.4 Merck mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments and Future Plans
2.5 Aldevron
2.5.1 Aldevron Details
2.5.2 Aldevron Major Business
2.5.3 Aldevron mRNA Vaccine Core Enzyme Product and Solutions
2.5.4 Aldevron mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aldevron Recent Developments and Future Plans
2.6 Qiagen N.V.
2.6.1 Qiagen N.V. Details
2.6.2 Qiagen N.V. Major Business
2.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Product and Solutions
2.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qiagen N.V. Recent Developments and Future Plans
2.7 Promega
2.7.1 Promega Details
2.7.2 Promega Major Business
2.7.3 Promega mRNA Vaccine Core Enzyme Product and Solutions
2.7.4 Promega mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Promega Recent Developments and Future Plans
2.8 Roche CustomBiotech
2.8.1 Roche CustomBiotech Details
2.8.2 Roche CustomBiotech Major Business
2.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Solutions
2.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche CustomBiotech Recent Developments and Future Plans
2.9 Takara Bio Inc.
2.9.1 Takara Bio Inc. Details
2.9.2 Takara Bio Inc. Major Business
2.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Solutions
2.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Takara Bio Inc. Recent Developments and Future Plans
2.10 Novoprotein
2.10.1 Novoprotein Details
2.10.2 Novoprotein Major Business
2.10.3 Novoprotein mRNA Vaccine Core Enzyme Product and Solutions
2.10.4 Novoprotein mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novoprotein Recent Developments and Future Plans
2.11 Vazyme
2.11.1 Vazyme Details
2.11.2 Vazyme Major Business
2.11.3 Vazyme mRNA Vaccine Core Enzyme Product and Solutions
2.11.4 Vazyme mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vazyme Recent Developments and Future Plans
2.12 Hongene Biotech Corporatio
2.12.1 Hongene Biotech Corporatio Details
2.12.2 Hongene Biotech Corporatio Major Business
2.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Solutions
2.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hongene Biotech Corporatio Recent Developments and Future Plans
2.13 Yeasen Biotechnology
2.13.1 Yeasen Biotechnology Details
2.13.2 Yeasen Biotechnology Major Business
2.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Solutions
2.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Yeasen Biotechnology Recent Developments and Future Plans
3.1 Global mRNA Vaccine Core Enzyme Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of mRNA Vaccine Core Enzyme by Company Revenue
3.2.2 Top 3 mRNA Vaccine Core Enzyme Players Market Share in 2022
3.2.3 Top 6 mRNA Vaccine Core Enzyme Players Market Share in 2022
3.3 mRNA Vaccine Core Enzyme Market: Overall Company Footprint Analysis
3.3.1 mRNA Vaccine Core Enzyme Market: Region Footprint
3.3.2 mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
3.3.3 mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global mRNA Vaccine Core Enzyme Consumption Value and Market Share by Enzyme Type (2018-2023)
4.2 Global mRNA Vaccine Core Enzyme Market Forecast by Enzyme Type (2024-2029)
5.1 Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2023)
5.2 Global mRNA Vaccine Core Enzyme Market Forecast by Application (2024-2029)
6.1 North America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
6.2 North America mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
6.3 North America mRNA Vaccine Core Enzyme Market Size by Country
6.3.1 North America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
6.3.2 United States mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
6.3.3 Canada mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
6.3.4 Mexico mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
7.1 Europe mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
7.2 Europe mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
7.3 Europe mRNA Vaccine Core Enzyme Market Size by Country
7.3.1 Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
7.3.2 Germany mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
7.3.3 France mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
7.3.4 United Kingdom mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
7.3.5 Russia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
7.3.6 Italy mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8.1 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
8.2 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
8.3 Asia-Pacific mRNA Vaccine Core Enzyme Market Size by Region
8.3.1 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2029)
8.3.2 China mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8.3.3 Japan mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8.3.4 South Korea mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8.3.5 India mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8.3.7 Australia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
9.1 South America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
9.2 South America mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
9.3 South America mRNA Vaccine Core Enzyme Market Size by Country
9.3.1 South America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
9.3.2 Brazil mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
9.3.3 Argentina mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
10.1 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
10.2 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
10.3 Middle East & Africa mRNA Vaccine Core Enzyme Market Size by Country
10.3.1 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
10.3.2 Turkey mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
10.3.4 UAE mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
11.1 mRNA Vaccine Core Enzyme Market Drivers
11.2 mRNA Vaccine Core Enzyme Market Restraints
11.3 mRNA Vaccine Core Enzyme Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 mRNA Vaccine Core Enzyme Industry Chain
12.2 mRNA Vaccine Core Enzyme Upstream Analysis
12.3 mRNA Vaccine Core Enzyme Midstream Analysis
12.4 mRNA Vaccine Core Enzyme Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Vaccine Core Enzyme Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Major Business
Table 7. Thermo Fisher mRNA Vaccine Core Enzyme Product and Solutions
Table 8. Thermo Fisher mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Recent Developments and Future Plans
Table 10. NEB Company Information, Head Office, and Major Competitors
Table 11. NEB Major Business
Table 12. NEB mRNA Vaccine Core Enzyme Product and Solutions
Table 13. NEB mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. NEB Recent Developments and Future Plans
Table 15. TriLink Bio Technologies Company Information, Head Office, and Major Competitors
Table 16. TriLink Bio Technologies Major Business
Table 17. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Solutions
Table 18. TriLink Bio Technologies mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. TriLink Bio Technologies Recent Developments and Future Plans
Table 20. Merck Company Information, Head Office, and Major Competitors
Table 21. Merck Major Business
Table 22. Merck mRNA Vaccine Core Enzyme Product and Solutions
Table 23. Merck mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck Recent Developments and Future Plans
Table 25. Aldevron Company Information, Head Office, and Major Competitors
Table 26. Aldevron Major Business
Table 27. Aldevron mRNA Vaccine Core Enzyme Product and Solutions
Table 28. Aldevron mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Aldevron Recent Developments and Future Plans
Table 30. Qiagen N.V. Company Information, Head Office, and Major Competitors
Table 31. Qiagen N.V. Major Business
Table 32. Qiagen N.V. mRNA Vaccine Core Enzyme Product and Solutions
Table 33. Qiagen N.V. mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Qiagen N.V. Recent Developments and Future Plans
Table 35. Promega Company Information, Head Office, and Major Competitors
Table 36. Promega Major Business
Table 37. Promega mRNA Vaccine Core Enzyme Product and Solutions
Table 38. Promega mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Promega Recent Developments and Future Plans
Table 40. Roche CustomBiotech Company Information, Head Office, and Major Competitors
Table 41. Roche CustomBiotech Major Business
Table 42. Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Solutions
Table 43. Roche CustomBiotech mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Roche CustomBiotech Recent Developments and Future Plans
Table 45. Takara Bio Inc. Company Information, Head Office, and Major Competitors
Table 46. Takara Bio Inc. Major Business
Table 47. Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Solutions
Table 48. Takara Bio Inc. mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Takara Bio Inc. Recent Developments and Future Plans
Table 50. Novoprotein Company Information, Head Office, and Major Competitors
Table 51. Novoprotein Major Business
Table 52. Novoprotein mRNA Vaccine Core Enzyme Product and Solutions
Table 53. Novoprotein mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Novoprotein Recent Developments and Future Plans
Table 55. Vazyme Company Information, Head Office, and Major Competitors
Table 56. Vazyme Major Business
Table 57. Vazyme mRNA Vaccine Core Enzyme Product and Solutions
Table 58. Vazyme mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Vazyme Recent Developments and Future Plans
Table 60. Hongene Biotech Corporatio Company Information, Head Office, and Major Competitors
Table 61. Hongene Biotech Corporatio Major Business
Table 62. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Solutions
Table 63. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Hongene Biotech Corporatio Recent Developments and Future Plans
Table 65. Yeasen Biotechnology Company Information, Head Office, and Major Competitors
Table 66. Yeasen Biotechnology Major Business
Table 67. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Solutions
Table 68. Yeasen Biotechnology mRNA Vaccine Core Enzyme Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Yeasen Biotechnology Recent Developments and Future Plans
Table 70. Global mRNA Vaccine Core Enzyme Revenue (USD Million) by Players (2018-2023)
Table 71. Global mRNA Vaccine Core Enzyme Revenue Share by Players (2018-2023)
Table 72. Breakdown of mRNA Vaccine Core Enzyme by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in mRNA Vaccine Core Enzyme, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key mRNA Vaccine Core Enzyme Players
Table 75. mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
Table 76. mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
Table 77. mRNA Vaccine Core Enzyme New Market Entrants and Barriers to Market Entry
Table 78. mRNA Vaccine Core Enzyme Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global mRNA Vaccine Core Enzyme Consumption Value (USD Million) by Enzyme Type (2018-2023)
Table 80. Global mRNA Vaccine Core Enzyme Consumption Value Share by Enzyme Type (2018-2023)
Table 81. Global mRNA Vaccine Core Enzyme Consumption Value Forecast by Enzyme Type (2024-2029)
Table 82. Global mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023)
Table 83. Global mRNA Vaccine Core Enzyme Consumption Value Forecast by Application (2024-2029)
Table 84. North America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2023) & (USD Million)
Table 85. North America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2024-2029) & (USD Million)
Table 86. North America mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America mRNA Vaccine Core Enzyme Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2023) & (USD Million)
Table 91. Europe mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2024-2029) & (USD Million)
Table 92. Europe mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe mRNA Vaccine Core Enzyme Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2023) & (USD Million)
Table 103. South America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2024-2029) & (USD Million)
Table 104. South America mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America mRNA Vaccine Core Enzyme Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 114. mRNA Vaccine Core Enzyme Raw Material
Table 115. Key Suppliers of mRNA Vaccine Core Enzyme Raw Materials
List of Figures
Figure 1. mRNA Vaccine Core Enzyme Picture
Figure 2. Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type in 2022
Figure 4. Capping Enzyme
Figure 5. 2'-O-Methyltransferase
Figure 6. Inorganic Pyrophosphatase
Figure 7. Poly (A) Polymerase
Figure 8. Rnase Inhibitor
Figure 9. RNA Polymerase
Figure 10. Restriction Enzyme
Figure 11. Dnase I
Figure 12. Others
Figure 13. Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type, (USD Million), 2018 & 2022 & 2029
Figure 14. mRNA Vaccine Core Enzyme Consumption Value Market Share by Application in 2022
Figure 15. Biopharmaceutical Companies Picture
Figure 16. Academic and Research Institutes Picture
Figure 17. Global mRNA Vaccine Core Enzyme Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global mRNA Vaccine Core Enzyme Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market mRNA Vaccine Core Enzyme Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2018-2029)
Figure 21. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Region in 2022
Figure 22. North America mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 25. South America mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 27. Global mRNA Vaccine Core Enzyme Revenue Share by Players in 2022
Figure 28. mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players mRNA Vaccine Core Enzyme Market Share in 2022
Figure 30. Global Top 6 Players mRNA Vaccine Core Enzyme Market Share in 2022
Figure 31. Global mRNA Vaccine Core Enzyme Consumption Value Share by Enzyme Type (2018-2023)
Figure 32. Global mRNA Vaccine Core Enzyme Market Share Forecast by Enzyme Type (2024-2029)
Figure 33. Global mRNA Vaccine Core Enzyme Consumption Value Share by Application (2018-2023)
Figure 34. Global mRNA Vaccine Core Enzyme Market Share Forecast by Application (2024-2029)
Figure 35. North America mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type (2018-2029)
Figure 36. North America mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2029)
Figure 37. North America mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 38. United States mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type (2018-2029)
Figure 42. Europe mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 45. France mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type (2018-2029)
Figure 50. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2018-2029)
Figure 52. China mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 55. India mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 58. South America mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type (2018-2029)
Figure 59. South America mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2029)
Figure 60. South America mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type (2018-2029)
Figure 64. Middle East and Africa mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 69. mRNA Vaccine Core Enzyme Market Drivers
Figure 70. mRNA Vaccine Core Enzyme Market Restraints
Figure 71. mRNA Vaccine Core Enzyme Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of mRNA Vaccine Core Enzyme in 2022
Figure 74. Manufacturing Process Analysis of mRNA Vaccine Core Enzyme
Figure 75. mRNA Vaccine Core Enzyme Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Thermo Fisher NEB TriLink Bio Technologies Merck Aldevron Qiagen N.V. Promega Roche CustomBiotech Takara Bio Inc. Novoprotein Vazyme Hongene Biotech Corporatio Yeasen Biotechnology
Related Reports
03 Apr 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
